- Home
- SGMT vs KULR Comparison
SGMT vs KULR Comparison
Compare SGMT & KULR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGMT | KULR |
|---|---|---|
| Founded | 2006 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Electrical Products |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.6M | 163.0M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | SGMT | KULR |
|---|---|---|
| Price | $5.74 | $3.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 1 |
| Target Price | $27.00 | ★ $40.00 |
| AVG Volume (30 Days) | 566.6K | ★ 1.1M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 45.49 | ★ 55.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,000,000.00 | $1,274,028.00 |
| Revenue This Year | N/A | $64.40 |
| Revenue Next Year | N/A | $105.13 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.73 | $0.73 |
| 52 Week High | $11.41 | $7.49 |
Technical Indicators
Market Signals| Indicator | SGMT | KULR |
|---|---|---|
| Relative Strength Index (RSI) | 51.03 | 49.91 |
| Support Level | $5.60 | $2.94 |
| Resistance Level | $6.72 | $3.13 |
| Average True Range (ATR) | 0.33 | 0.22 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 62.78 | 79.82 |
Price Performance
Historical ComparisonAbout SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About KULR KULR Technology Group Inc.
KULR Technology Group Inc develops and commercializes high-performance thermal management technologies for electronics, batteries, and other components. The company is focused on targeting the following applications: electric vehicles and autonomous driving systems, artificial intelligence and Cloud computing, energy storage, 5G communication technologies, and other consumer and industrial devices.